PROTAC BRD4 Degrader-15 is a proteolysis targeting chimera (PROTAC) used in research to selectively degrade the BRD4 protein via the ubiquitin-proteasome system. BRD4 plays a significant role in regulating gene expression and is implicated in diseases such as certain cancers. This compound is valuable for studying BRD4-related pathologies, including leukemia, lymphoma, and other malignancies, as well as exploring roles in inflammation and neurological disorders. By inducing targeted protein degradation, it aids researchers in understanding BRD4 function, validating it as a therapeutic target, and assessing PROTAC-based drug discovery approaches. It is intended for laboratory research use.